Treat Gut
Precision microbiota transplant therapy for intestinal microecology, offering comprehensive solutions for human microecological health
About Treat Gut
Founded in 2016 by Xiao Chuanxing, TreatGut is a biopharmaceutical company specializing in intestinal microecology.
The company focuses on developing and providing precision microbiota transplant therapy. This therapy is designed to offer comprehensive solutions for human microecological health. TreatGut has an integrated business model that includes research and development, manufacturing, sales, and service, enabling it to control the entire value chain from innovation to market delivery.
TreatGut's core offering is a comprehensive solution for precise bacterial transplantation treatment. This involves the transplantation of functional flora from healthy donors to patients to rebuild a healthy intestinal microecology. The company serves clients in the healthcare sector, providing them with advanced therapies for various health issues related to intestinal microecology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 17.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Drug Development, Gastroenterology, Microbiome, DT and LS, science-based
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2025 | $14M | $55M | Jinhe Capital | ↗ |
| SEEDEquity / VC | Mar 2019 | $1.4M | $5.5M | Grower Venture Capital · Sunz Fund | — |
Growth signals
Latest recorded traffic for Treat Gut is 240 monthly website visits, down 22.6% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Treat Gut in the Guilin Shi ecosystem
The Treat Gut office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- GIGuangzhou Improve Medical Instruments
- GCGrower Venture Capital
- SFSunz Fund
Series A1 investor entered at this stage
- JCJinhe Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Treat Gut on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Treat Gut’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








